Further efforts are needed to determine whether the anti-tumor ability of AAG8 antagonists and the resistance could be translated in vivo, because this may have implications for developing AAG8 antagonists as novel anti-cancer drugs. The gene discussed is SIGMAR1; the disease is neoplasm.